鸢尾素调控牙周组织修复再生的作用及机制进展
Regulatory Roles and Mechanisms of Irisin in Periodontal Tissue Repair and Regeneration
DOI: 10.12677/hjbm.2026.166101, PDF,   
作者: 刘俊吉:重庆医科大学口腔医学院,重庆;重庆医科大学附属口腔医院牙周科,重庆;向学熔*:重庆医科大学附属口腔医院牙周科,重庆
关键词: 鸢尾素;牙周炎;牙周组织再生;骨免疫;线粒体稳态;Irisin; Periodontitis; Periodontal Regeneration; Osteoimmunology; Mitochondrial Homeostasis
摘要: 牙周炎组织缺损修复需控制炎症,重建牙周复合体结构与功能。鸢尾素是多肽类物质,现有研究表明其具有免疫调节、抗氧化及骨代谢调控作用,可促进牙周膜细胞增殖、迁移、细胞外基质形成及成骨/成牙骨质分化,经多条信号通路缓解炎症和牙槽骨丢失。但直接证据仍局限于细胞及动物研究,人体研究匮乏。本文综述鸢尾素的分子基础、骨免疫调控、直接依据与递送策略,辨析已知机制与推测性通路,提出临床转化的关键研究方向。
Abstract: Repair of periodontitis-related defects requires the control of inflammation and the reconstruction of the structure and function of the periodontal complex. Irisin is a polypeptide substance. Existing evidence indicates that irisin exerts immunomodulatory, antioxidant and bone-metabolic regulatory effects. It can promote the proliferation, migration, extracellular matrix formation and osteogenic/ cementogenic differentiation of periodontal ligament cells, and alleviate inflammation and alveolar bone loss via multiple signaling pathways. However, evidence remains limited to cell and animal studies, and human studies are scarce. This review summarizes the molecular basis of irisin, osteoimmunological regulation, direct evidence and delivery strategies, distinguishes known mechanisms from putative pathways, and puts forward key research directions for clinical translation.
文章引用:刘俊吉, 向学熔. 鸢尾素调控牙周组织修复再生的作用及机制进展[J]. 生物医学, 2026, 16(6): 984-991. https://doi.org/10.12677/hjbm.2026.166101

参考文献

[1] Abdulkareem, A.A., Al-Taweel, F.B., Al-Sharqi, A.J.B., Gul, S.S., Sha, A. and Chapple, I.L.C. (2023) Current Concepts in the Pathogenesis of Periodontitis: From Symbiosis to Dysbiosis. Journal of Oral Microbiology, 15, Article 2197779.
https://doi.org/10.1080/20002297.2023.2197779
[2] Kwon, T., Lamster, I.B. and Levin, L. (2021) Current Concepts in the Management of Periodontitis. International Dental Journal, 71, 462-476.
https://doi.org/10.1111/idj.12630
[3] Sirisereephap, K., Maekawa, T., Tamura, H., Hiyoshi, T., Domon, H., Isono, T., et al. (2022) Osteoimmunology in Periodontitis: Local Proteins and Compounds to Alleviate Periodontitis. International Journal of Molecular Sciences, 23, Article 5540.
https://doi.org/10.3390/ijms23105540
[4] Chen, S., Gao, X. and Song, J. (2023) Oxidative Stress-Related Biomarkers in Chronic Periodontitis Patients with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Periodontal Research, 58, 780-790.
https://doi.org/10.1111/jre.13136
[5] Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., et al. (2012) A PGC1-α-Dependent Myokine That Drives Brown-Fat-Like Development of White Fat and Thermogenesis. Nature, 481, 463-468.
https://doi.org/10.1038/nature10777
[6] Kim, H., Wrann, C.D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., et al. (2018) Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. Cell, 175, 1756-1768.e17.
https://doi.org/10.1016/j.cell.2018.10.025
[7] Pullisaar, H., Colaianni, G., Lian, A., Vandevska-Radunovic, V., Grano, M. and Reseland, J.E. (2020) Irisin Promotes Growth, Migration and Matrix Formation in Human Periodontal Ligament Cells. Archives of Oral Biology, 111, Article 104635.
https://doi.org/10.1016/j.archoralbio.2019.104635
[8] Huang, X., Xiao, J., Wang, X. and Cao, Z. (2022) Irisin Attenuates P. Gingivalis-Suppressed Osteogenic/Cementogenic Differentiation of Periodontal Ligament Cells via P38 Signaling Pathway. Biochemical and Biophysical Research Communications, 618, 100-106.
https://doi.org/10.1016/j.bbrc.2022.06.001
[9] Li, G., Qin, H., Zhou, M., Zhang, T., Zhang, Y., Ding, H., et al. (2023) Knockdown of SIRT3 Perturbs Protective Effects of Irisin against Bone Loss in Diabetes and Periodontitis. Free Radical Biology and Medicine, 200, 11-25.
https://doi.org/10.1016/j.freeradbiomed.2023.02.023.
[10] Hu, W., Lu, Y., Duan, Y., Yang, Y., Wang, M., Guo, J., et al. (2024) Regulation of Immune Inflammation and Promotion of Periodontal Bone Regeneration by Irisin-Loaded Bioactive Glass Nanoparticles. Langmuir, 40, 3440-3452.
https://doi.org/10.1021/acs.langmuir.3c02894
[11] Maak, S., Norheim, F., Drevon, C.A. and Erickson, H.P. (2021) Progress and Challenges in the Biology of FNDC5 and Irisin. Endocrine Reviews, 42, 436-456.
https://doi.org/10.1210/endrev/bnab003
[12] Paoletti, I. and Coccurello, R. (2024) Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology. International Journal of Molecular Sciences, 25, Article 13480.
https://doi.org/10.3390/ijms252413480
[13] Liu, S., Cui, F., Ning, K., Wang, Z., Fu, P., Wang, D., et al. (2022) Role of Irisin in Physiology and Pathology. Frontiers in Endocrinology, 13, Article 962968.
https://doi.org/10.3389/fendo.2022.962968
[14] Cosio, P.L., Pelaez, M., Cadefau, J.A. and Farran-Codina, A. (2023) Systematic Review and Meta-Analysis of Circulating Irisin Levels Following Endurance Training: Results of Continuous and Interval Training. Biological Research for Nursing, 25, 367-381.
https://doi.org/10.1177/10998004221142580
[15] Torabi, A., Reisi, J., Kargarfard, M. and Mansourian, M. (2024) Differences in the Impact of Various Types of Exercise on Irisin Levels: A Systematic Review and Meta-Analysis. International Journal of Preventive Medicine, 15, 1-11.
https://doi.org/10.4103/ijpvm.ijpvm_76_23
[16] Hatakeyama, J., Inoue, S., Jiang, H., Yokoi, R. and Moriyama, H. (2025) Exercise-Induced Interactions between Skeletal Muscle and Bone via Myokines and Osteokine in Mice: Role of FNDC5/Irisin, IGF-1, and Osteocalcin. Bone, 190, Article 117314.
https://doi.org/10.1016/j.bone.2024.117314
[17] Mu, A., Wales, T.E., Zhou, H., et al. (2023) Irisin Acts through Its Integrin Receptor in a Two-Step Process Involving Extracellular Hsp90α. Molecular Cell, 83, 1903-1920.e12.
https://doi.org/10.1016/j.molcel.2023.05.008
[18] Bai, Z., Chen, Z., Sun, T., Ma, C. and Meng, A. (2025) Potential Role of Integrin αV as Irisin Receptor and Advances in Research. Peptides, 193, Article 171439.
https://doi.org/10.1016/j.peptides.2025.171439
[19] Hu, X., Wang, Z., Wang, W., Cui, P., Kong, C., Chen, X., et al. (2024) Irisin as an Agent for Protecting against Osteoporosis: A Review of the Current Mechanisms and Pathways. Journal of Advanced Research, 62, 175-186.
https://doi.org/10.1016/j.jare.2023.09.001
[20] Zhao, R., Chen, Y., Wang, D., Zhang, C., Song, H. and Ni, G. (2023) Role of Irisin in Bone Diseases. Frontiers in Endocrinology, 14, Article 1212892.
https://doi.org/10.3389/fendo.2023.1212892
[21] Chen, Y., Wang, H., Yang, Q., Zhao, W., Chen, Y., Ni, Q., et al. (2022) Single-Cell RNA Landscape of the Osteoimmunology Microenvironment in Periodontitis. Theranostics, 12, 1074-1096.
https://doi.org/10.7150/thno.65694
[22] Hu, K., Shang, Z., Yang, X., Zhang, Y. and Cao, L. (2023) Macrophage Polarization and the Regulation of Bone Immunity in Bone Homeostasis. Journal of Inflammation Research, 16, 3563-3580.
https://doi.org/10.2147/jir.s423819
[23] 贺欣然, 李元, 张武阳, 等. 牙周炎中巨噬细胞极化、焦亡、胞葬的研究进展[J]. 口腔疾病防治, 2024, 32(11): 886-893.
[24] Zhang, M., Liu, Y., Afzali, H. and Graves, D.T. (2024) An Update on Periodontal Inflammation and Bone Loss. Frontiers in Immunology, 15, Article 1385436.
https://doi.org/10.3389/fimmu.2024.1385436
[25] 刘旭芳, 马雨轩, 牛丽娜. 线粒体功能障碍在牙周炎发生、发展及治疗中作用的研究进展[J]. 口腔疾病防治, 2023, 31(12): 889-895.
[26] 黄珺玲, 王津津, 王勤涛. 牙周炎环境下人牙龈成纤维细胞线粒体稳态的失衡[J]. 口腔疾病防治, 2024, 32(12): 916-924.
[27] Tang, H., Zhou, Y., Ma, L., Ye, Y., Xiao, Q., Tang, J., et al. (2025) SIRT3 Alleviates Mitochondrial Dysfunction and Senescence in Diabetes-Associated Periodontitis by Deacetylating LRPPRC. Free Radical Biology and Medicine, 227, 407-419.
https://doi.org/10.1016/j.freeradbiomed.2024.11.033
[28] Li, G., Jian, Z., Wang, H., Xu, L., Zhang, T. and Song, J. (2022) Irisin Promotes Osteogenesis by Modulating Oxidative Stress and Mitophagy through SIRT3 Signaling under Diabetic Conditions. Oxidative Medicine and Cellular Longevity, 2022, Article 3319056.
https://doi.org/10.1155/2022/3319056
[29] Zhu, X., Li, X., Wang, X., Chen, T., Tao, F., Liu, C., et al. (2020) Irisin Deficiency Disturbs Bone Metabolism. Journal of Cellular Physiology, 236, 664-676.
https://doi.org/10.1002/jcp.29894
[30] Yang, Y., Pullisaar, H., Landin, M.A., Heyward, C.A., Schröder, M., Geng, T., et al. (2021) FNDC5/Irisin Is Expressed and Regulated Differently in Human Periodontal Ligament Cells, Dental Pulp Stem Cells and Osteoblasts. Archives of Oral Biology, 124, Article 105061.
https://doi.org/10.1016/j.archoralbio.2021.105061
[31] Yang, Y., Geng, T., Samara, A., Olstad, O.K., He, J., Agger, A.E., et al. (2023) Recombinant Irisin Enhances the Extracellular Matrix Formation, Remodeling Potential, and Differentiation of Human Periodontal Ligament Cells Cultured in 3D. Journal of Periodontal Research, 58, 336-349.
https://doi.org/10.1111/jre.13094
[32] Yang, Y., Pullisaar, H., Stunes, A.K., Nogueira, L.P., Syversen, U. and Reseland, J.E. (2023) Irisin Reduces Orthodontic Tooth Movement in Rats by Promoting the Osteogenic Potential in the Periodontal Ligament. European Journal of Orthodontics, 45, 842-853.
https://doi.org/10.1093/ejo/cjad021
[33] Wu, S., Wang, J., Liu, L., Pang, Y., Li, Z. and Mu, H. (2023) Recombinant Irisin Protects against Alveolar Bone Destruction during Orthodontic Tooth Movement. Inflammation, 46, 1106-1117.
https://doi.org/10.1007/s10753-023-01797-3
[34] Yang, Y., Wang, M., Zhang, G., Lu, X., Liu, S., Chen, Y., et al. (2025) Irisin-Based Nanocomposites for Antioxidant Purpose and the Promotion of Osteogenesis in the Inflammatory Microenvironment. Langmuir, 41, 23036-23049.
https://doi.org/10.1021/acs.langmuir.5c02711
[35] Chen, Y., Xu, Z., Xue, Y., Liu, S., Zhang, X., Guo, J., et al. (2026) Cascade Therapy of Periodontitis via Sequential Release of Ribosome-Targeting Antimicrobial Peptide and Irisin from a Multifunctional MOF-Based System. Advanced Science, 13, e21553.
https://doi.org/10.1002/advs.202521553
[36] 李伟光, 吴亚菲, 郭淑娟. 无机纳米粒子在牙周病诊疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(6): 724-730.
[37] 杨梦瑶, 高现灵, 邓淑丽. 静电纺丝纳米纤维在牙周再生中的应用[J]. 国际口腔医学杂志, 2023, 50(1): 10-18.
[38] Turkmen, E., Uzun, E.V., Bozaba, F., Balci, N. and Toygar, H. (2023) Salivary Irisin Level Is Higher and Related with Interleukin-6 in Generalized Periodontitis. Clinical Oral Investigations, 27, 3001-3008.
https://doi.org/10.1007/s00784-023-04903-9
[39] Salim, F.S. and Saliem, S.S. (2025) Irisin, a Promising Adipomyokine, Shows Low Levels in Relation to Periodontal Diseases, Unlike Visfatin and IL-6 (Case-Control Study). Frontiers in Oral Health, 6, Article 1614433.
https://doi.org/10.3389/froh.2025.1614433
[40] Saribas, E., Kandemir, M., Erkan, R.E.C. and Tuncer, M.C. (2025) Evaluation of Irisin and Interleukin-6 Levels in Saliva Samples of Periodontally Healthy and Stage 3 Grade C Periodontitis Individuals. Biology, 14, Article 1188.
https://doi.org/10.3390/biology14091188